Explore Fate Therapeutics' pipeline, financials, and market position to assess if its 75% drop reflects true value or ...

Presented positive 4- and 12-week clinical results of ongoing type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplan ...

Oklahoma scientists find interferon-beta may help MS patients on B cell therapy fight infections like flu and Covid-19, new ...

Updated clinical data in heavily pre-treated, CAR-T naïve patients with B-NHL shows prolonged duration of response, with ...

Phase 1 clinical data of INB-100 continues to demonstrate long-term durable remissions, with 100% of treated Acute Myeloid ...

One of the best ways to maximize absorption is through proper gut health. Before trying vitamin supplements, it's important ...

Often dubbed the "sunshine vitamin," Vitamin D plays a critical role in numerous bodily functions, far beyond just bone ...

To overcome these limitations, Antengene developed ATG-201, a "2+1" CD19 x CD3 TCE, which was evaluated in a series of in vitro studies for binding affinity, T cell dependent cytotoxicity (TDCC) ...

T cell engagers (TCEs) represent a groundbreaking advancement in the treatment of B and plasma cell malignancies and are ... Through a CRISPR screen, deficiency in FUT8 (Fucosyltransferase 8) ...

a differentiated B cell depletion therapy for autoimmune diseases. Cue Biopharma is a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage ...